Joanna Opalińska

825 citations
27 papers · 284 indexed · h-index 8
Topics
Multiple Myeloma Research and Treatments (26 papers)Protein Degradation and Inhibitors (9 papers)Monoclonal and Polyclonal Antibodies Research (7 papers)
Journals
Journal of Clinical OncologySHILAP Revista de lepidopterologíaBlood

In The Last Decade

Joanna Opalińska

26 papers receiving 276 citations

Peers

Joanna Opalińska
Comparison fields: 5 of 30
  • Hematology 245
  • Oncology 188
  • Molecular Biology 153
  • Radiology, Nuclear Medicine and Imaging 90
  • Immunology 23
Replace Albert Oriol Rocafiguera with:
Albert Oriol Rocafiguera Spain
Andrew Dalovisio United States
Tara Stephenson United States
Katarina Uttervall Sweden
Laura Moreno Spain
Nika M Harutyunyan United States
Robin Carson United States
Francesca Bonello Italy
Pia Sondergeld Germany
Wojciech Janowski Australia
Joanna Opalińska relative to Albert Oriol Rocafiguera Spain Albert Oriol Rocafiguera's profile →
Citations per field
00.5×2.9×
Albert Oriol Rocafiguera · 1×
Citations per year

Countries citing papers authored by Joanna Opalińska

Since Specialization
Citations

This map shows the geographic impact of Joanna Opalińska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joanna Opalińska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joanna Opalińska more than expected).

Fields of papers citing papers by Joanna Opalińska

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joanna Opalińska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joanna Opalińska. The network helps show where Joanna Opalińska may publish in the future.

Co-authorship network of co-authors of Joanna Opalińska

This figure shows the co-authorship network connecting the top 25 collaborators of Joanna Opalińska. A scholar is included among the top collaborators of Joanna Opalińska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joanna Opalińska. Joanna Opalińska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 2
4 2
5 3
6 11
7 6
8 100
9 15
10 9
11
Dreamm-4: evaluating safety and clinical activity of belantamab mafodotin (belamaf) in combination with pembrolizumab in patients with relapsed/refractory multiple myeloma (rrmm)
1
12 2
13 4
14 6
15 31
16 1
17 4
18 23
19 3
20 1

About Joanna Opalińska

Joanna Opalińska is a scholar working on Hematology, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 27 papers that have together received 284 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (26 papers), Protein Degradation and Inhibitors (9 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). The work is most often cited by research in Hematology (245 citations), Oncology (188 citations) and Radiology, Nuclear Medicine and Imaging (90 citations). Joanna Opalińska has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Katja Weisel, Ira Gupta, Sagar Lonial, Trisha Piontek, Adam D. Cohen, Ashraf Badros, Roxanne C. Jewell, Suzanne Trudel, Natalie S. Callander and Ajay K. Nooka. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026